<DOC>
	<DOCNO>NCT01306409</DOCNO>
	<brief_summary>The purpose study gain information reticulocyte neocytolysis patient treat ESA regard different type ESA .</brief_summary>
	<brief_title>Neocytolysis Treatment Renal Anemia With Erythropoieses Stimulating Agents ( ESA )</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<mesh_term>Hematinics</mesh_term>
	<criteria>sign informed consent age &gt; 18 year , dialysis dependent chronic renal failure hemodialysis three time week Kt/V &gt; 1,2 od URR &gt; 65 % hemoglobin 11 13 g/dl within last 2 month hemoglobin change +/ 1g/dl within last 4 week ESA least 8 week Ferritin &gt; 300 ng/ml Tsat &gt; 25 % Significant bleeding last 8 week blood transfusion within last 8 week hemoglobin disorder hemolysis Malignant disease Significant inflammation Acute infection CRP &gt; 30 mg/l Temporary vascular dialysis access Vitamin B12 deficiency Folic acid deficiency Not control hyperparathyroidism Not control hypertension Epilepsia within thze last 6 month Thrombocyte count &gt; 500 x 10^9 /l</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>anemia</keyword>
	<keyword>kidney disease</keyword>
</DOC>